$9.12 0.13 (+1.45%)
11/25/2009 9:44 AM

ABIOMED, Inc. (ABMD)

CAPS Rating: 2 out of 5

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

Results 1 - 10 of 10

Recs

0
Member Avatar Displacement (91.54) Submitted: 9/16/2009 10:40:13 PM : Outperform Start Price: $8.94 ABMD Score: -3.50

I really like these technicals and if it gets some volume and starts breaking its resistance around $9 I can see it going to 11 or 12. We'll see, it's a maybe.

Recs

0
Member Avatar ScreenerStizBear (32.24) Submitted: 6/26/2008 2:26:22 PM : Underperform Start Price: $18.47 ABMD Score: +40.09

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recs

1
Member Avatar dlee210 (< 20) Submitted: 6/24/2008 5:41:09 PM : Outperform Start Price: $18.01 ABMD Score: -37.02

Has the first total transplantable artificial heart. This company has the innovation to create more medical products that will soon be approved and used.

Recs

1
Member Avatar Sqwii (< 20) Submitted: 6/16/2008 10:56:05 AM : Outperform Start Price: $18.98 ABMD Score: -36.98

short term pick, equity nr. 2 list

Recs

0
Member Avatar LetterA (28.09) Submitted: 4/6/2008 3:01:41 AM : Outperform Start Price: $13.50 ABMD Score: -15.85

Testing a portfolio of companies that start with the letter "A".

Recs

0
Member Avatar samlove (< 20) Submitted: 1/2/2008 1:52:55 PM : Outperform Start Price: $15.46 ABMD Score: -20.91

On a strictly technical basis, my magic charts say this will outperform the S&P

Recs

0
Member Avatar FlorisHJ (71.74) Submitted: 7/24/2007 3:01:27 PM : Outperform Start Price: $10.63 ABMD Score: +8.76

Once the Impella 2.5 & 5 get FDA approval in the US (patient erollment for study complete; Canadian and European approval already achieved) they will start making money and you will see this stock boom. Get in now while it's still cheap.

Recs

0
Member Avatar 80brown (97.62) Submitted: 6/1/2007 10:05:11 AM : Underperform Start Price: $11.77 ABMD Score: -1.51

This one is volatile; it is trading at 327% intrinsic value, although we may see the price climb higher before it finally goes back down.

Recs

0
Member Avatar whansard (< 20) Submitted: 12/4/2006 4:55:37 PM : Outperform Start Price: $12.75 ABMD Score: -12.38

I like it

Recs

0
Member Avatar freewillyb (< 20) Submitted: 12/4/2006 4:19:32 PM : Outperform Start Price: $12.75 ABMD Score: -12.38

New product line acquired last year propelling expanded cardiac treatment suite

Results 1 - 10 of 10

Featured Broker Partners